Effective extracorporeal treatment of metformin-associated lactic acidosis using continuous venovenous hemodiafiltration

Autor: Mèdea Brouwer, Mandy Offermans, Lisanne van Nuil, Astrid Poukens, Brigit van Oijen, Tom Dormans

Publikováno v: European Journal of Case Reports in Internal Medicine (2024)

Background: The prevalence of type 2 diabetes mellitus has surged globally. Metformin is recommended as the first-line oral treatment. However, metformin-associated lactic acidosis (MALA) is recognized as a rare but potentially dangerous complication

Externí odkaz: https://doaj.org/article/fb132d5eea384d97bb106a221f0072e3

Urinary neutrophil gelatinase-associated lipocalin and plasma IL-6 in discontinuation of continuous venovenous hemodiafiltration for severe acute kidney injury: a multicenter prospective observational study

Autor: Yohei Komaru, Moe Oguchi, Tomohito Sadahiro, Taka-aki Nakada, Noriyuki Hattori, Takeshi Moriguchi, Junko Goto, Hidetoshi Shiga, Yoshihiko Kikuchi, Shigeo Negi, Takashi Shigematsu, Naohide Kuriyama, Tomoyuki Nakamura, Kent Doi

Publikováno v: Annals of Intensive Care, Vol 13, Iss 1, Pp 1-10 (2023)

Abstract Background Patients with severe acute kidney injury (AKI) who require continuous venovenous hemodiafiltration (CVVHDF) in intensive care unit (ICU) are at high mortality risk. Little is known about clinical biomarkers for risk prediction, op

Externí odkaz: https://doaj.org/article/f6338621fb144bada33a4c3ad3065c28

Ceftazidime-avibactam (CAZ-AVI) pharmacokinetics in critically ill patients undergoing continuous venovenous hemodiafiltration (CVVHDF).

Autor: O'Jeanson A; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Ioannidis K; Clinical pharmacist, Hygeia General Hospital, Athens, Greece., Nielsen EI; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Galani L; 1(st) Department of Internal Medicine & Infectious Diseases, Hygeia General Hospital, Athens, Greece., Ginosyan A; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Paskalis H; ICU, Hygeia General Hospital, Athens, Greece., Loryan I; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Giamarellou H; 1(st) Department of Internal Medicine & Infectious Diseases, Hygeia General Hospital, Athens, Greece., Friberg LE; Department of Pharmacy, Uppsala University, Uppsala, Sweden. Electronic address: lena.friberg@farmaci.uu.se., Karaiskos I; 1(st) Department of Internal Medicine & Infectious Diseases, Hygeia General Hospital, Athens, Greece.

Publikováno v: International journal of antimicrobial agents [Int J Antimicrob Agents] 2024 Nov 23; Vol. 65 (1), pp. 107394. Date of Electronic Publication: 2024 Nov 23.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Hypercitratemia is a mortality predictor among patients on continuous venovenous hemodiafiltration and regional citrate anticoagulation

Autor: Thais Oliveira Claizoni dos Santos, Carlos Eduardo dos Santos Ferreira, Cristóvão Luis Pitangueira Mangueira, Adriano Luiz Ammirati, Patricia Faria Scherer, Marisa Petrucelli Doher, Thais Nemoto Matsui, Bento Fortunato Cardoso dos Santos, Virgílio Gonçalves Pereira, Marcelo Costa Batista, Julio Cesar Martins Monte, Oscar Fernando Pavão Santos, Marcelino de Souza Durão

Publikováno v: Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)

Abstract The use of regional citrate anticoagulation (RCA) in liver failure (LF) patients can lead to citrate accumulation. We aimed to evaluate serum levels of citrate and correlate them with liver function markers and with the Cat/Cai in patients u

Externí odkaz: https://doaj.org/article/427d0018e2a64d16926b8ee27c914af0